Edyta Walterska Ms

Edyta Walterska possesses extensive experience in clinical operations and project management within the pharmaceutical industry. Currently serving as Asset Lead and Senior Director at Daiichi Sankyo, Inc., since January 2024, Edyta has previously held senior leadership roles at Ultragenyx Pharmaceutical Inc. and AstraZeneca, where responsibilities included global development and oncology program management. Edyta's background also includes positions at Gilead Sciences Ltd, Avid Bioservices, and Seattle Genetics, showcasing a progressive career trajectory in clinical operations. Edyta's educational qualifications include a Master of Science in Microbiology from the University of Warsaw, an MBA from Golden Gate University, and a postgraduate qualification in Project Management from Szkoła Główna Handlowa w Warszawie.